Karyopharm Therapeutics Inc. 401(k) Plan
Sponsored by Karyopharm Therapeutics Inc. · EIN 263931704 · Plan #001
- Total assets
- $55.6M
- Net assets
- $55.6M
- Active participants
- 284
- With balances
- 484
Plan year beginning 01/01/2024 · 401(k)
Linked investment advisers
Advisory firms matched from Schedule C service providers (investment codes 26-28).
No linked investment advisers.
Service providers
Schedule C providers paid $5,000+ (large plans only).
| Provider | Services | Direct comp |
|---|---|---|
| Fidelity Investments Institutional | Participant loan processing, Recordkeeping fees, Account maintenance fees | $62,878 |